Groups (Treatment) | Mortality | Behavioral and body weight changes |
---|---|---|
Phase I | ||
Group 1 (10 mg/kg b.w. EESAL) | 0/3 | Not significant |
Group 2 (100 mg/kg b.w. EESAL) | 0/3 | Not significant |
Group 3 (100 mg/kg b.w. EESAL) | 0/3 | Not significant |
Phase II | ||
Group 4 (1600 mg/kg b.w. EESAL) | 0/3 | Not significant |
Group 5 (2900 mg/kg b.w. EESAL) | 0/3 | Not significant |
Group 6 (5000 mg/kg b.w. EESAL) | 0/3 | Not significant |